Irina Nikolaevna Kadiyala,Shahla Jamzad,Thomas Carl Hoock,Lori Kell Taylor,Kathryn Lea Sewell
申请号：
US14271589
公开号：
US20140243273A1
申请日:
2014.05.07
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides method of treating or lessening the severity of a disease selected from spondyloarthropathy, systemic lupus erythematosus, rheumatoid arthritis, or any combination thereof comprising the administration of a compound of Formula I and an optional co-therapy (e.g., chemotherapy agent, DMARD, or any combination thereof). The present invention also provides a pharmaceutical composition comprising a compound of Formula I, a method of manufacturing a pharmaceutical composition comprising a compound of Formula I, and a method of administering a pharmaceutical composition comprising a solid form of a compound of Formula I.
